Fred M. Powell
Director of Finance/CFO presso LAVA THERAPEUTICS N.V.
Patrimonio netto: 166 500 $ in data 31/03/2024
Profilo
Fred M.
Powell currently works at LAVA Therapeutics NV, as Chief Financial Officer from 2022 and Youth Orchestra of Bucks County, as Treasurer from 2017.
Mr. Powell also formerly worked at Antares Pharma, Inc., as Chief Financial Officer & Executive Vice President from 2017 to 2022, OraPharma, Inc., as Chief Financial Officer from 2011 to 2012, Eximias Pharmaceutical Corp., as Chief Financial Officer from 2002 to 2004, Celator Pharmaceuticals, Inc., as Chief Financial Officer & Vice President from 2013 to 2016, Beijing Med-Pharm Corp., as Chief Financial Officer from 2005 to 2008, KPMG Peat Marwick LLP, as Senior Manager from 1983 to 1989, InnaPhase Corp., as Senior Vice President-Finance & Administration from 1999 to 2002, Premier Research Worldwide Ltd., as Chief Financial Officer from 1996 to 1999, and BMP Sunstone Corp., as Chief Financial Officer & Head-Media Relations from 2005 to 2011.
Mr. Powell received his undergraduate degree in 1983 from The Pennsylvania State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LAVA THERAPEUTICS NV
0.19% | 28/02/2023 | 50 000 ( 0.19% ) | 166 500 $ | 31/03/2024 |
Posizioni attive di Fred M. Powell
| Società | Posizione | Inizio |
|---|---|---|
| LAVA THERAPEUTICS N.V. | Director of Finance/CFO | 01/11/2022 |
| Youth Orchestra of Bucks County | Treasurer | 01/06/2017 |
Precedenti posizioni note di Fred M. Powell
| Società | Posizione | Fine |
|---|---|---|
| ANTARES PHARMA, INC. | Director of Finance/CFO | 24/05/2022 |
| CELATOR PHARMACEUTICALS INC | Director of Finance/CFO | 12/07/2016 |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Director of Finance/CFO | 01/12/2012 |
BMP Sunstone Corp.
 BMP Sunstone Corp. Medical/Nursing ServicesHealth Services BMP Sunstone Corp. manufactures, markets and distributes over-the-counter products. The company was founded in November 2003 and is headquartered in Montgomery, PA. | Director of Finance/CFO | 01/01/2011 |
| Beijing Med-Pharm Corp. | Director of Finance/CFO | 19/02/2008 |
Formazione di Fred M. Powell
| The Pennsylvania State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LAVA THERAPEUTICS N.V. | Health Technology |
| Aziende private | 10 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Health Technology |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Celator Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. The company was founded by Lawrence David Mayer, and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ. | Health Technology |
| Beijing Med-Pharm Corp. | Distribution Services |
| KPMG Peat Marwick LLP | Commercial Services |
InnaPhase Corp.
 InnaPhase Corp. Packaged SoftwareTechnology Services InnaPhase Corporation provides innovative technology solutions for early drug development teams. The company's software technologies allow clients to maximize their drug development pipeline. InnaPhase leverages scientific experience with advanced software and clinical database technologies to provide specialized systems that are powerful, yet easy to use, and highly scalable. | Technology Services |
| Premier Research Worldwide Ltd. | Commercial Services |
BMP Sunstone Corp.
BMP Sunstone Corp. Medical/Nursing ServicesHealth Services BMP Sunstone Corp. manufactures, markets and distributes over-the-counter products. The company was founded in November 2003 and is headquartered in Montgomery, PA. | Health Services |
| Youth Orchestra of Bucks County |
- Borsa valori
- Insiders
- Fred M. Powell
